Pharmaceutical Policy in Canada
Canada's health care system, more importantly, the pharmaceutical policy is the under federal and provincial levels of government. In Canada, citizens have a publicly funded health care system with universal access to the Medicare system. The Canada Health Act provides “near-universal” coverage across the nation. Moreover, the government has failed in improving health care results and in altering policy decisions to make a strategic plan. Physicians also play a significant role in contributing to the healthcare facilities and on how they satisfy their patients. In Canada, prescription drug plans vary across the nation. There is a universal prescription drug coverage in Canada that varies throughout each province …show more content…
For example, when it comes to spending on Type 2 diabetes drugs by private insurance plans in Canada, 30 percent of the time doctors prescribed vastly more expensive drugs without first trying cheaper alternatives. (pg. 8)
Hence, it shows that the high spending’s on diabetes medication has resulted in the diabetes association of Canada to first prescribe generic drugs like Metformin. This diabetes medication only costs $65 per year. Morgan (2003) found: “Pharmaceutical companies are required to use the same active ingredients in generic drugs as the brand name version, and generic prescriptions must meet the same quality and safety standards” (pg. 9). Pharmaceutical policies in Canada should focus on substitution laws and cost-effectiveness to make Canada a healthier place. According to Khosla et al., “Direct-to-consumer advertising (DTCA) promote its prescription products directly to patients. Patient Medication Adherence and health outcomes in patients” (pg. 483). Universal prescription drug coverage in Canada should provide necessary services without direct charges to the patient. Morgan states: In clinical terms, there is no scientific evidence of systemic differences in outcomes across countries, drug plans, or hospitals with widely varying rates of generic drug use” (pg. …show more content…
The rapid growth in expenditures has resulted in pharmaceutical companies to increase prescription medication prices, however, provide poor quality medicines. “Since increasing the price of pharmaceuticals has little effect on their demand, consumers and the public bear the consequences of high prices” (Witktorowicz, 2010, p. 304). The authors examine Patented Medicine Prices Review Board (PMPRB), which protects consumers in ensuring the prices in Canada from wholesalers, hospitals, pharmacies or other, are not excessively priced. Hence, it provides a vision of pharmaceutical companies investing long-term investments for themselves. It analyzes the government's decision towards the health care system; whether or not, how health is the Canadian health-care system. Thus, pharmaceutical companies promote brand-name medicines over generic drugs that worth the same. Prescription drug prices have been on the rise in Canada. Drug costs, drug prices and the bargaining power of universal schemes. “The Canadian Institute for Health Information reported in 2013 that Canada’s per capita spending was second only to that of the United States among seven comparator countries” (pg.189). Patented, unpatented drugs and generic drugs influence drug prices. Medication adherence in the elderly can affect the effectiveness of the drug and can change the utilization for what the patient is consuming.
Canada's health care system, more importantly, the pharmaceutical policy is the under federal and provincial levels of government. In Canada, citizens have a publicly funded health care system with universal access to the Medicare system. The Canada Health Act provides “near-universal” coverage across the nation. Moreover, the government has failed in improving health care results and in altering policy decisions to make a strategic plan. Physicians also play a significant role in contributing to the healthcare facilities and on how they satisfy their patients. In Canada, prescription drug plans vary across the nation. There is a universal prescription drug coverage in Canada that varies throughout each province …show more content…
For example, when it comes to spending on Type 2 diabetes drugs by private insurance plans in Canada, 30 percent of the time doctors prescribed vastly more expensive drugs without first trying cheaper alternatives. (pg. 8)
Hence, it shows that the high spending’s on diabetes medication has resulted in the diabetes association of Canada to first prescribe generic drugs like Metformin. This diabetes medication only costs $65 per year. Morgan (2003) found: “Pharmaceutical companies are required to use the same active ingredients in generic drugs as the brand name version, and generic prescriptions must meet the same quality and safety standards” (pg. 9). Pharmaceutical policies in Canada should focus on substitution laws and cost-effectiveness to make Canada a healthier place. According to Khosla et al., “Direct-to-consumer advertising (DTCA) promote its prescription products directly to patients. Patient Medication Adherence and health outcomes in patients” (pg. 483). Universal prescription drug coverage in Canada should provide necessary services without direct charges to the patient. Morgan states: In clinical terms, there is no scientific evidence of systemic differences in outcomes across countries, drug plans, or hospitals with widely varying rates of generic drug use” (pg. …show more content…
The rapid growth in expenditures has resulted in pharmaceutical companies to increase prescription medication prices, however, provide poor quality medicines. “Since increasing the price of pharmaceuticals has little effect on their demand, consumers and the public bear the consequences of high prices” (Witktorowicz, 2010, p. 304). The authors examine Patented Medicine Prices Review Board (PMPRB), which protects consumers in ensuring the prices in Canada from wholesalers, hospitals, pharmacies or other, are not excessively priced. Hence, it provides a vision of pharmaceutical companies investing long-term investments for themselves. It analyzes the government's decision towards the health care system; whether or not, how health is the Canadian health-care system. Thus, pharmaceutical companies promote brand-name medicines over generic drugs that worth the same. Prescription drug prices have been on the rise in Canada. Drug costs, drug prices and the bargaining power of universal schemes. “The Canadian Institute for Health Information reported in 2013 that Canada’s per capita spending was second only to that of the United States among seven comparator countries” (pg.189). Patented, unpatented drugs and generic drugs influence drug prices. Medication adherence in the elderly can affect the effectiveness of the drug and can change the utilization for what the patient is consuming.